Theriva Biologics, Inc. Property, Plant and Equipment
Theriva Biologics, Inc. (TOVX) had Property, Plant and Equipment of $173.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-11
- 2026-06-30: Property, Plant and Equipment, Net $173.00K.
- 2026-03-31: Property, Plant and Equipment, Net $194.00K.
- 2025-12-31: Property, Plant and Equipment, Net $222.00K.
- 2025-09-30: Property, Plant and Equipment, Net $249.00K.
| Period end | Property, Plant and Equipment, Net | Property, Plant and Equipment, Net as first filed |
|---|---|---|
| 2026-06-30 | $173.00K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $194.00K 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $222.00K 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $249.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $258.00K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $253.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $270.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $314.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $336.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $375.00K 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $422.00K 10-K · filed 2025-03-06 | |
| 2023-09-30 | $389.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $301.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $324.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $345.00K 10-K · filed 2024-03-25 | |
| 2022-09-30 | $262.00K 10-K · filed 2023-03-30 | |
| 2022-06-30 | $285.00K 10-K · filed 2023-03-30 | |
| 2022-03-31 | $302.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $101.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $115.00K 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $132.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $156.00K 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $174.00K 10-K · filed 2022-03-16 | |
| 2020-09-30 | $202.00K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $251.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $309.00K 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $367.00K 10-K · filed 2021-03-04 | |
| 2019-09-30 | $425.00K 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $485.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $545.00K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $607.00K 10-K · filed 2020-02-20 | |
| 2018-09-30 | $665.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $731.00K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $801.00K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $872.00K 10-K · filed 2019-02-27 | |
| 2017-09-30 | $943.00K 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $800.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $859.00K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $905.00K 10-K · filed 2018-02-22 | |
| 2016-09-30 | $582.00K 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $482.00K 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $501.00K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $494.00K 10-K · filed 2017-03-02 | |
| 2015-09-30 | $483.00K 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $107.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $75.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $65.00K 10-K · filed 2016-03-10 | |
| 2014-09-30 | $67.00K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $51.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $38.00K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $37.00K 10-K · filed 2015-03-16 | |
| 2013-09-30 | $157.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $155.00K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $215.00K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $223.00K 10-K · filed 2014-03-31 | |
| 2012-09-30 | $249.00K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $254.00K 10-Q/A · filed 2012-09-11 | |
| 2012-03-31 | $303.00K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $323.00K 10-K · filed 2013-04-16 | |
| 2011-09-30 | $371.46K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $396.14K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $475.00K 10-K/A · filed 2012-05-11 | $511.14K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |